Sort by
Refine Your Search
-
Listed
-
Field
-
to therapies and vaccines against human diseases. We are a team of highly interactive investigators that have expertise in immunology, molecular biology, virology, microbiology, structural biology, computational
-
/PhD Degree Experience Background in cardiac biology, neurobiology, bioengineering, or related field Molecular biology Background in electrophysiology preferred but not required Skills Skills in mouse
-
to work independently in team-oriented projects, and are consistent, responsible and accurate for scientific research. As part of the Multi-Ethnic Study of Atherosclerosis (MESA), successful candidates will
-
. Occupational Summary Conduct independent research activities under the guidance of a faculty mentor in preparation for a academic or research career. Work Performed A Postdoctoral position at Duke University is
-
factors associated with successful colonization of Lactobacillus crispatus in the vaginal and urinary microbiome, using biospecimens from an interventional trial. · Humanized Mouse Model of UTI: We use germ
-
position is funded by multiple NIH projects, e.g., https://tinyurl.co m/ysxhmujvThe overall goal is to : (1) develop inference and dynamic prediction models using a wide variety of data, including clinical
-
inhalation exposures. We use in vitro, rodent, and non-rodent models to achieve our study objectives. We will employ various techniques/methods such as ELISA, multiplex MSD panel assays, flow cytometry, bulk
-
of responsible conduct in research. Comply with good scholarly and research practice. Adhere to University standards regarding use of isotopes, chemicals, infectious agents, animals, human subjects, and the like
-
programming languages (e.g., Python, MATLAB, R, or Julia). Curate and integrate experimental data to calibrate and validate models, including parameter estimation and uncertainty quantification. Work
-
-Doctoral Research Fellow Outline 2025-26 Purpose: The primary focus of this role will be to oversee clinical translation of a novel EGFRvIII x CD3 bi-specific T cell engager for the treatment of glioblastoma